5Strous GJ,Govers R.The ubiquitin proteasome system and endocytosis[J].Cell Sci,1999,112:1417-1423.
6Hicke L.Getting' down with ubiquitin:turning off cell surface receptors.transporters and channels[J].Trends Cell Biol,1999,9:107-112.
7Laney JD,Hochstrasser M.Substrate targeting in the ubiquitin systern[J].Cell,1999,97:427-430.
8Koepp DM,Harper JW,Eledge SJ.How the cyclin became acyclir regulated proteolysis in the cell cycle[J].Cell,1999,97:431-434.
9Kotani S,Tanaka H,Yasuda H,et al.Regulation of APC activity by phosphorylation and regulatory factors[J].J Cell Biol,1999,146:791-800.
10Bachmair A,Finley D,Vatshavsky A.In vivo half life of a protein is a function of its amino terminal residue[J].Science,1986,234(4773):179-186.
二级参考文献47
1Pickart CM, Eddins MJ. Ubiquitin: structure, functions, mechanisms[J]. Biochim Biophys Acta ,2004,1695 ( 1-3 ) :55-72.
2Glickman MH, Ciechanovor A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction [ J ]. Physiol Rev,2002,82 (2) :373-428.
3Chung CH, Baek SH. Deubiquitinating enzymes: their diversity and emerging roles[ J]. Biochem Biophys Res Commun, 1999,266( 3 ) :633-640.
4Hatakeyama S, Nakayama KI. U-box proteins as a new family of ubiquitin ligases[J]. Biochem Biophys Res Commun,2003 ,302( 4 ) :635-645.
5Burger AM, Seth AK. The ubiquitin-mediated protein degradation pathway in cancer :therapeutic implications[ J ]. Eur J Cancer,2004,40(15) :2217-2229.
6Bachmair A, Finley D, Varshavsky A. In vivo half-life of a protein isa function of its amino-terminal residue[ J]. Science, 1986, 234(4773) :179-186.
7Roger DE, Michayla M, Anne O,et al. A novel ubiquitin- specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein[J]. EMBO J, 1997, 16(3):566-577.
8Muyang L, Delin C, Ariel S, et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization[J]. Nature,2002,416(6881 ) :648-653.
9Daniel K ,Claus S. A pervasive role of ubiquitin conjugation in activation and termination of IkB kinase pathways[J]. EMBO Reports,2005,6(4 ) :321-326.
10Simon R ,Struckmann K, Schraml P. Amplliication pattern of 12q13-q15 genes (MDM2 CDK4, GLI) in urinary bladder cancer[J]. Oncogene ,2002,21 ( 16 ) :2476-2483.
3Bird A.DNA methylation patterns and epigenetic memory[J].Genes Dev,2002,16(1):6-21.
4Dario LS,Rosa MA,Mariela E,et al.Chromatin remodeling agents for cancer therapy[J].Rev Recent Clin Trials,2008,3(3):192-203.
5Liu K,Harland RM.Cloning and characterization of express id4 reveals differing roles for id genes[J].Dev Biol,2003,264:339-351.
6Ortmann CA,Eiseke L,Nückel H,et al.Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia[J].Ann Hematol,2008,87:809-818.
7Issa JP.CpG island methylator phenotype in cancer[J].Nat Rev Cancer,2004,4(12):988-993.
8Jones PA,Baylin SB.The fundamental role of epigenetic events in cancer[J].Nat Rev Genet,2002,3(6):415-428.
9Pui CH,Evans WE.Treatment of acute lymphoblastic leukemia[J].Engl J Med,2006,354:166-178.
10Matsuyama A,Shimazu T,Sumida Y,et al.In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation[J].EMBO J,2002,21(24):6820-6831.
